Global Health & Biotech Archives | Page 14 of 286 | Be Korea-savvy

Archive by category Global Health & Biotech

Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs

Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs

Milestones underscore Resmed’s leadership and commitment to delivering life-changing health technology that people love SAN DIEGO, Aug. 21, 2025 (Korea Bizwire) — Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced that its AirTouch™ N30i nasal cradle mask won two prestigious Red Dot Awards: Product [...]

Indonesia’s PP No. 28/2024 Threatens to Reinforce Cigarette Use Through Misguided Regulation

Indonesia’s PP No. 28/2024 Threatens to Reinforce Cigarette Use Through Misguided Regulation

JAKARTA, Indonesia, Aug. 21, 2025 (Korea Bizwire) — The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) today warned that Indonesia’s proposed PP No. 28 Tahun 2024 risks undermining public health and entrenching cigarette dominance by restricting access to proven harm reduction alternatives. Indonesia is one of the world’s largest cigarette markets, where millions [...]

The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA): Tobacco Harm Reduction Advocates Demand Urgent Change As Australia’s Tobacco Wars Expose Global Policy Failures

The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA): Tobacco Harm Reduction Advocates Demand Urgent Change As Australia’s Tobacco Wars Expose Global Policy Failures

WELLINGTON, New Zealand, Aug. 20, 2025 (Korea Bizwire) – The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) believes that as Australia’s tobacco control strategy descends into chaos with over 125 fire bombings, a thriving A$6.3 billion illicit market, and smoking rates stagnating at 11%, leading tobacco harm reduction advocates are calling for an [...]

Zymeworks Announces Participation in Upcoming Investor Conferences

Zymeworks Announces Participation in Upcoming Investor Conferences

VANCOUVER, British Columbia, Aug. 19, 2025 (Korea Bizwire) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced that management will participate in the following upcoming investor conferences: Citi’s Biopharma Back [...]

Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio

Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio

Mowad-Nassar is Senior Vice President at AbbVie and President, Specialty and U.S. Therapeutics Operations Her appointment brings over 30 years of strategic, commercial, and operational expertise in the pharmaceutical and broader healthcare industry, with a focus on digital innovation SAN DIEGO, Aug. 18, 2025 (Korea Bizwire) – Resmed (NYSE: RMD, ASX: RMD) today announced the [...]

Extrovis AG and Dr. Reddy’s announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S.

Extrovis AG and Dr. Reddy’s announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S.

Extrovis AG Bahnhof Park 4 6340, Baar, Switzerland Media Relations Contact Madhu Marur madhu.marur@extrovis.com                                          Press Release Extrovis AG and Dr. Reddy’s announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S. Baar, Switzerland; August 14, 2025 Extrovis AG, a global pharmaceutical company focused on research-driven innovation, and Dr. Reddy’s [...]

Boehringer Ingelheim and Palatin Technologies to develop potential first-in-class melanocortin receptor targeted treatment for patients with retinal diseases

Boehringer Ingelheim and Palatin Technologies to develop potential first-in-class melanocortin receptor targeted treatment for patients with retinal diseases

Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. (Image from the company HQ) Collaboration strengthens Boehringer’s pipeline in Eye Health. Many patients with diabetic retinopathy (DR) continue to experience vision loss or treatment fatigue, underscoring an unmet need. Melanocortin receptor agonists offer a promising, differentiated mechanism that targets key [...]

EAACI Launches Global Antibiotic Allergy Awareness Campaign at EAACI Congress 2025

EAACI Launches Global Antibiotic Allergy Awareness Campaign at EAACI Congress 2025

ZURICH, Aug. 15, 2025 (Korea Bizwire) — EAACI has launched its Antibiotic Allergy Awareness Campaign during its 2025 Congress in Glasgow. The initiative begins a global effort to address mislabelling and its link to antimicrobial resistance (AMR). A Global Call to Action Antibiotic allergy mislabelling affects millions worldwide. Inaccurate labels lead to avoidance of first-line [...]

AAVantgarde Bio Announces FDA Fast Track Designation for AAVB-039 for the Treatment of Stargardt Disease

AAVantgarde Bio Announces FDA Fast Track Designation for AAVB-039 for the Treatment of Stargardt Disease

MILAN, Aug. 12, 2025 (Korea Bizwire) — AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company developing next-generation gene therapies for inherited retinal diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for AAVB-039, the company’s gene therapy program for Stargardt disease secondary to biallelic mutation in ABCA4. The Investigational [...]

Sandoz launches renewable energy partnership to cover nearly 90% of electricity demand for European operations

Sandoz launches renewable energy partnership to cover nearly 90% of electricity demand for European operations

  MEDIA RELEASE Sandoz signs 10-year virtual PPA with Elawan Energy for new 150 MW solar projects in Spain Will cover nearly 90% of electricity demand for European operations Concrete step to support global Sandoz decarbonization efforts and sustainability commitment Basel, August 12, 2025 – Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, today [...]